Glatiramer acetate for multiple sclerosis

References

Citations

  1. Simpson D, et al. (2003). Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis. Biodrugs, 17(3): 207–210.

  2. National Clinical Advisory Board of the National Multiple Sclerosis Society (2007). Disease Management Consensus Statement. New York: National Multiple Sclerosis Society. Available online: http://www.nationalmssociety.org/site/PageServer?pagename=HOM_PRO_expert_opinion_papers.


Author: Monica RhodesLast Updated: February 28, 2008
Medical Review: Anne C. Poinier, MD - Internal Medicine
Colin Chalk, MD, CM, FRCPC - Neurology

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise

Topic Contents
 Examples
 How It Works
 Why It Is Used
 How Well It Works
 Side Effects
 What To Think About
 References